Wusu, Tacheng Prefecture, Xinjiang, China admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:



Trelagliptin Succinate: Product Description and Physical Properties

What is Trelagliptin Succinate?

Trelagliptin Succinate belongs to a newer class of oral medications for type 2 diabetes management. As a dipeptidyl peptidase-4 (DPP-4) inhibitor, this compound offers a weekly dosing schedule, setting it apart from daily alternatives. The molecule has become essential for those needing glucose regulation, due to its effects on prolonging active incretin levels. That means increased insulin release and reduced glucagon secretion. Real relief for patients tired of rigid pill routines.

Chemical Structure and Molecular Formula

The active ingredient features the chemical formula C22H27N5O4 and appears as a combination of trelagliptin and succinic acid, merging to form a salt that gives enhanced pharmacological and physical stability. The unique structure creates a favorable profile for absorption and metabolic breakdown. Its molecular weight stands at roughly 441.5 g/mol, a detail that influences how the drug dissolves and is processed inside the body.

Specifications and Appearance

Trelagliptin Succinate typically presents as a white to off-white crystalline powder. The solid material does not exhibit strong odors. Handling it, the powder flows easily and adheres to surfaces, making good laboratory practices critical. Not every batch appears identical, but there’s a reliable fineness to the powder with crystal-like granularity. Depending on processing, small flakes or pearls may form, especially in bulk storage or after prolonged transit. Density runs close to 1.31 g/cm³. That value affects storage and transport, helping suppliers gauge packing volumes and stability during shipment.

Solubility and Solution Properties

In water, Trelagliptin Succinate exhibits moderate solubility, dissolving more efficiently in warm or neutral pH aqueous media. Solutions remain clear without heavy sediment. Any formulation expert handling the raw material needs to carefully control solvent choice and agitation speed to ensure the substance dissolves evenly. Improper mixing can result in incomplete dispersion, affecting finished product consistency.

HS Code and Raw Material Sourcing

Importers and distributors file the compound under HS Code 2935009090 — a category for heterocyclic compounds with nitrogen hetero-atom(s) only. This classification streamlines international trade, customs clearance, and regulatory reporting. Raw material quality matters here, as impurities can slow or block customs processes. Buyers sourcing the chemical from regions with advanced pharmaceutical standards—such as the United States, Japan, or western Europe—benefit from better traceability, batch documentation, and analytical testing.

Safe Handling, Hazardous and Harmful Properties

Trelagliptin Succinate does not exude caustic vapors or fumes, but personal protective equipment (PPE) still remains non-negotiable during handling. Long-term exposure risks stay low if proper controls remain in place; eye protection and gloves help keep accidental contact at bay. Standard hazard sheets list the material as low-to-moderate risk, but dust inhalation or skin contact may create mild irritation. Those operating in confined or poorly ventilated spaces should work with extraction fans or fume hoods. Cleaning up spills with damp cloths or HEPA-filtered vacuums works better than dry sweeping, avoiding aerosolization of fine powders. Despite a relatively favorable safety profile, the compound should not find its way into municipal water or food systems. Secure waste disposal, guided by local environmental regulations, prevents adverse environmental or health impact.

Material Utility and Industry Insights

Trelagliptin Succinate matters most for companies working in pharmaceutical manufacturing and advanced formulation development, especially those targeting diabetes mellitus type 2. Production at scale hinges on reliable raw material inputs, which underscores the importance of supplier transparency and batch consistency. The market for DPP-4 inhibitors expands every year, as diabetes prevalence rises. Regulatory agencies care deeply about the source, documentation, and quality controls surrounding every shipment, making traceability just as crucial as purity or physical specs. Material handlers, chemists, and warehouse operators all have a stake in understanding not just what the powder is, but how its characteristics might change with time, transit, or blending with other actives and excipients.